Translating the Science of Allergy and Immunology into Clinical Medicine

In this presentation, Dr. David P. Huston, Professor in the Departments of Medicine and Microbial Pathogenesis and Immunology and Associate Dean of the College of Medicine at Texas A&M Health Science Center, updates the audience on recent advances in the fields of allergy and immunology. He  decribes recent insights into disease processes for the type 2 immune response disorders included in the Atopic March: allergic eczema, allergic rhinitis with or without nasal polyps, and allergic asthma. He also reviews recent FDA-approved biologics for the treatment of these conditions.

Dr. Huston discusses the clinical case of a 3-year old girl who presents with pulmonary alveolar proteinosis with a genetic abnormality, and explains how his team identified the etiology of this disease.

CME Information

CME Credit Available

You may claim CME credit after watching this activity.

Needs Statement

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of medicine and quality improvement to increase clinical knowledge. This Grand Rounds series also aims to provide learners with the appropriate skills to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.


At the conclusion of this activity, the participant should be able to:

  • Discuss recent advances in understanding the molecular mechanism of allergic inflammatory disorders.
  • Apply mechanistic insights on allergic inflammation into strategies for developing therapres for allergic inflammatory disorders.
  • Translate potential therapeutic strategies for allergic inflammatory disorders into a precision clinical medicine approach for managing patients

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Director

Richard J. Hamill, M.D.
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Term of Approval

August 1, 2019 through August 31, 2021. Original release date: August 1, 2019.

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.


The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:


  1. David P. Huston, M.D.

    David P. Huston, M.D.

    Professor of Microbial Pathogenesis & Immunology
    Texas A&M University College of Medicine


    Nothing to disclose.

CME Credit Available

You may claim CME credit after watching this activity.

View the CME Information Take the Post-Test Now


  1. David P. Huston, M.D.

    David P. Huston, M.D.

    Professor of Microbial Pathogenesis & Immunology Texas A&M University College of Medicine